ZA895143B - Diagnosing and treating chronic fatigue syndrome - Google Patents

Diagnosing and treating chronic fatigue syndrome

Info

Publication number
ZA895143B
ZA895143B ZA895143A ZA895143A ZA895143B ZA 895143 B ZA895143 B ZA 895143B ZA 895143 A ZA895143 A ZA 895143A ZA 895143 A ZA895143 A ZA 895143A ZA 895143 B ZA895143 B ZA 895143B
Authority
ZA
South Africa
Prior art keywords
chronic fatigue
fatigue syndrome
diagnosing
treating chronic
levels
Prior art date
Application number
ZA895143A
Other languages
English (en)
Inventor
William A Carter
A Carter William
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of ZA895143B publication Critical patent/ZA895143B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA895143A 1988-07-07 1989-07-06 Diagnosing and treating chronic fatigue syndrome ZA895143B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22076588A 1988-07-07 1988-07-07

Publications (1)

Publication Number Publication Date
ZA895143B true ZA895143B (en) 1991-04-24

Family

ID=22824871

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895143A ZA895143B (en) 1988-07-07 1989-07-06 Diagnosing and treating chronic fatigue syndrome

Country Status (13)

Country Link
EP (1) EP0350151B1 (de)
CN (1) CN1056747C (de)
AT (1) ATE103493T1 (de)
AU (2) AU3781189A (de)
CA (1) CA1336685C (de)
DE (1) DE68914201T2 (de)
DK (1) DK332289A (de)
ES (2) ES2066847T3 (de)
IE (1) IE63927B1 (de)
IL (1) IL90875A (de)
NZ (1) NZ229849A (de)
PT (1) PT91094B (de)
ZA (1) ZA895143B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0495831B1 (de) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
US5776690A (en) * 1996-10-07 1998-07-07 Vojdani; Aristo Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO1999049029A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd Control of gene expression
EP2314700A1 (de) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Zusammensetzung und Verfahren zur in vivo und in vitro Abschwächung der Genexpression mittels dobbelsträngiger RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (de) 2001-01-31 2004-01-28 Nucleonics, Inc Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
US20120004290A1 (en) * 2009-03-13 2012-01-05 David Strayer Treating chronic fatigue syndrome and prolonged qt interval
EP3652542A1 (de) * 2017-07-14 2020-05-20 Protea Biopharma N.V. Verfahren und vorrichtungen zur diagnose und / oder behandlung einer ermüdungserkrankung
EP3893893A1 (de) * 2018-12-13 2021-10-20 Aim Immunotech Inc. Verfahren zur verbesserung der trainingstoleranz bei patienten mit encephalomyelitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
PH30882A (en) * 1987-03-03 1997-12-23 Hem Res Inc Activated Rnase L as a maker for viral infections.
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.

Also Published As

Publication number Publication date
IL90875A (en) 1994-04-12
IL90875A0 (en) 1990-02-09
DK332289A (da) 1990-01-08
CN1056747C (zh) 2000-09-27
AU3781189A (en) 1990-01-11
IE63927B1 (en) 1995-06-28
CN1039722A (zh) 1990-02-21
IE892180L (en) 1990-01-07
EP0350151A2 (de) 1990-01-10
ATE103493T1 (de) 1994-04-15
DE68914201T2 (de) 1994-07-14
PT91094A (pt) 1990-02-08
EP0350151A3 (en) 1990-10-03
ES2018903A6 (es) 1991-05-16
CA1336685C (en) 1995-08-15
AU6883694A (en) 1994-11-24
EP0350151B1 (de) 1994-03-30
ES2066847T3 (es) 1995-03-16
AU684288B2 (en) 1997-12-11
DK332289D0 (da) 1989-07-04
NZ229849A (en) 1997-07-27
PT91094B (pt) 1995-01-31
DE68914201D1 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
Shepherd et al. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association
Wing et al. Mood changes in behavioral weight loss programs
ZA895143B (en) Diagnosing and treating chronic fatigue syndrome
Erskine-Milliss et al. Relaxation therapy in asthma: a critical review
Berman et al. Eating attitudes in seasonal affective disorder and bulimia nervosa
Cheong et al. An epidemiological study of pityriasis rosea in Middle Road Hospital
Dawson et al. Diagnostic utility of autonomic measures for major depressive disorders
Jung et al. Paroxysmal choreoathetosis: report of Chinese cases
Ostfeld et al. Personality factors and pressor mechanisms in renal and essential hypertension
Garruti et al. Links between metabolic syndrome and cardiovascular autonomic dysfunction
Hynes Hypnotic treatment of five adult cases of trichotillomania.
HU9201196D0 (en) Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
Waller et al. When is sexual abuse relevant to bulimic disorders? The validity of clinical judgements
Feinberg Untreated type 2 diabetes as a cause of daytime somnolence
Pohl et al. Lactate and isoproterenol infusions in bulimic patients
Richards Research into aging: exploding myths
Mintz et al. " Cognitive-behavioral therapy in geriatric depression": Reply to Riskind, Beck, and Steer.
许以平 et al. RELATIONSHIP BETWEEN IgD AND ASTHMA
Saricam et al. The Coexistence of Obstructive Sleep Apnea in Patients with Slow Coronary Flow: Questionnaire Study
Ashkinazi Functional deficiency of erythrocyte thromboplastin factor
Klein Social adjustment in affective disorders
King et al. Da Costa's syndrome or neurocirculatory asthenia
Yiamouyiannis et al. Paracetamol pharmacokinetics are independent of caloric intake and physical activity
DE3572033D1 (en) Method for diagnosis of a.i.d.s.
Seregina Psychotherapy in the treatment of a patient with chronic renal failure